Zamotaev I P, Lozinskiĭ L G, Kerimova R E, Maĭchuk Iu F, Makarova L G
Kardiologiia. 1988 Oct;28(10):18-21.
Thirty-one patients who received a prolonged maintenance therapy with cordarone to treat and prevent cardiac arrhythmias underwent an ophthalmologic examination. The treatment lasted 1.5 to 51 months. The signs of keratopathy were detected in 24 (77.4%) patients using a slit lamp biomicroscopy. There is a relationship between the severity of keratopathy and a daily dose of cordarone: in most cases signs of stage I keratopathy were detectable when the daily dose was up to 200 mg. Keratopathy appears to be reversible after the drug has been discontinued.
31名接受可达龙长期维持治疗以治疗和预防心律失常的患者接受了眼科检查。治疗持续了1.5至51个月。使用裂隙灯生物显微镜检查在24名(77.4%)患者中检测到角膜病变迹象。角膜病变的严重程度与可达龙的每日剂量之间存在关联:在大多数情况下,当每日剂量高达200毫克时可检测到I期角膜病变迹象。停药后角膜病变似乎是可逆的。